417 related articles for article (PubMed ID: 11420459)
21. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
[TBL] [Abstract][Full Text] [Related]
22. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
23. The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears.
Sung CO; Kim SR; Oh YL; Song SY
Diagn Cytopathol; 2010 Mar; 38(3):168-71. PubMed ID: 19760769
[TBL] [Abstract][Full Text] [Related]
24. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic and viral (human papillomavirus) correlates of vulvar seborrheic keratosis.
Bai H; Cviko A; Granter S; Yuan L; Betensky RA; Crum CP
Hum Pathol; 2003 Jun; 34(6):559-64. PubMed ID: 12827609
[TBL] [Abstract][Full Text] [Related]
26. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.
Conesa-Zamora P; Doménech-Peris A; Orantes-Casado FJ; Ortiz-Reina S; Sahuquillo-Frías L; Acosta-Ortega J; García-Solano J; Pérez-Guillermo M
Am J Clin Pathol; 2009 Sep; 132(3):378-90. PubMed ID: 19687314
[TBL] [Abstract][Full Text] [Related]
27. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
28. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
29. p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.
Bala R; Pinsky BA; Beck AH; Kong CS; Welton ML; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):659-68. PubMed ID: 23552383
[TBL] [Abstract][Full Text] [Related]
30. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
[TBL] [Abstract][Full Text] [Related]
32. High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.
Cabibi D; Giannone AG; Quattrocchi A; Lo Coco R; Formisano E; Porcasi R; Benfante V; Comelli A; Capra G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791395
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of CINtec® PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer.
Yoshida T; Sano T; Kanuma T; Inoue H; Itoh T; Yazaki C; Obara M; Fukuda T
Acta Cytol; 2011; 55(5):413-20. PubMed ID: 21986167
[TBL] [Abstract][Full Text] [Related]
34. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
[TBL] [Abstract][Full Text] [Related]
37. [Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract][Full Text] [Related]
38. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P; Robova H; Rob L; Zamecnik J
Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.
Hu L; Guo M; He Z; Thornton J; McDaniel LS; Hughson MD
Mod Pathol; 2005 Feb; 18(2):267-73. PubMed ID: 15492761
[TBL] [Abstract][Full Text] [Related]
40. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
